Indoleamine 2,3-dioxygenase 1 (IDO1) is overexpressed in numerous tumors, including melanoma, breast cancer, and CRC (Chen et al., 2007; Soliman et al., 2013; Qian et al., 2016). This evidence concerns the gene IDO1 and breast carcinoma.